A 13-year study of prostate cancer screening finds it helps reduce deaths by 21%, but researchers still aren't sure the tests help more than they harm.
MASSDEVICE ON CALL — The prostate cancer screening debate rages on as a new study published in the journal Lancet vindicates the life-saving potential of testing but cautions against introducing routine screening programs.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1pdqtYm
Cap comentari:
Publica un comentari a l'entrada